Finance

Lists
603590:SHA
Beijing Konruns Pharmaceutical Co Ltd
CNÂ¥30.98
-0.67%
(-0.21) 1D
Oct 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603590...
Open
CNÂ¥31.33
High
CNÂ¥31.39
Low
CNÂ¥29.90
Mkt. cap
5.18B
Avg. vol.
2.68M
Volume
5.80M
Dividend
1.13%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jul 8, 2026
P/E ratio
28.90
52-wk high
CNÂ¥54.86
52-wk low
CNÂ¥27.33
EPS
CNÂ¥1.07
Shares outstanding
160.00M
No. of employees
793
Open
CNÂ¥31.33
High
CNÂ¥31.39
Low
CNÂ¥29.90
Mkt. cap
5.18B
Avg. vol.
2.68M
Volume
5.80M
Dividend
1.13%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jul 8, 2026
P/E ratio
28.90
52-wk high
CNÂ¥54.86
52-wk low
CNÂ¥27.33
EPS
CNÂ¥1.07
Shares outstanding
160.00M
No. of employees
793
News stories
From web sources and news partners
About Beijing Konruns Pharmaceutical Co Ltd
CEO-
Employees793
FoundedSep 3, 2003
Headquarters-
SectorPharmaceutical industry
Websitekonruns.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
231.35M
222.90M
214.87M
247.93M
Cost of goods sold
22.91M
24.09M
21.90M
25.26M
Cost of revenue
22.91M
24.09M
21.90M
25.26M
Research and development expenses
12.30M
19.06M
13.34M
26.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154.66M
141.77M
116.52M
141.17M
Operating expense
166.20M
167.04M
133.22M
168.99M
Total operating expenses
189.12M
191.13M
155.12M
194.26M
Operating income
42.23M
31.77M
59.75M
53.67M
Other non operating income
-14.51M
12.12M
-636.15K
584.04K
EBT including unusual items
38.44M
41.48M
58.70M
62.24M
EBT excluding unusual items
28.50M
47.88M
60.43M
61.01M
Income tax expense
475.46K
6.35M
10.19M
10.18M
Effective tax rate
1.24%
15.32%
17.36%
16.36%
Other operating expenses
113.66K
5.54M
1.21M
2.64M
Net income
36.83M
38.09M
47.21M
48.51M
Net profit margin
15.92%
17.09%
21.97%
19.57%
Earnings per share
-
-
-
-
Interest and investment income
1.19M
9.96M
3.52M
10.46M
Interest expense
-2.08M
-2.13M
-2.20M
-2.39M
Net interest expenses
-889.52K
7.84M
1.32M
8.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
49.22M
39.15M
67.12M
62.47M
Gain or loss from assets sale
130.67K
553.62K
-
-
AI content may include mistakes. Learn more
Google apps